XPD gene polymorphisms and the effects of induction chemotherapy in cytogenetically normal de novo acute myeloid leukemia patients

References

• Liesveld JL, Lichtman MA. Acute myelogenous leukemia. In: Kaushansky K, Lichtman MA, Beutler E, Kipps TJ, Seligsohn U, Prchal JT, (eds.) Williams Hematology. 8th ed. New York: McGraw-Hill; 2010. pp. 1277–330.
   Google Scholar
• Deschler B, Lubbert M. Acute myeloid leukemia: epidemiology and etiology. Cancer 2006;107:2099–107.
   PubMed Web of Science ®Google Scholar
• Baer MR, Greer JP. Acute myeloid leukemia in adults. In: Greer JP, Foerster J, Rodgers GM, Paraskevas F, Glader B, Arber DA, Means RT, (eds.) Wintrobe's clinical haematology. 12th ed. Philadelphia: Lippincott Williams & Wilkins; 2009. pp. 1843–89.
   Google Scholar
• Burnett AK, Venditti A. Acute myeloid leukaemia. In: Hoffbrand AV, Catovsky D, Tuddenham EG, Green AR, (eds.) Postgraduate haematology. 6th ed. Oxford: Blackwell Publishing; 2010. pp. 415–32.
   Google Scholar
• Kuptsova N, Kopecky KJ, Godwin J, Anderson J, Hoque A, Willman CL, et al. Polymorphisms in DNA repair genes and therapeutic outcomes of AML patients from SWOG clinical trials. Blood 2007;109:3936–44.
   PubMed Web of Science ®Google Scholar
• Branzei D, Foiani M. Regulation of DNA repair throughout the cell cycle. Nat Rev Mol Cell Biol. 2008;9:297–308.
   PubMed Web of Science ®Google Scholar
• López-Camarillo C, Lopez-Casamichana M, Weber C, Guillen N, Orozco E, Marchat LA. DNA repair mechanisms in eukaryotes: Special focus in Entamoeba histolytica and related protozoan parasites. Infect Genet Evol. 2009;9:1051–6.
   PubMed Web of Science ®Google Scholar
• Le May N, Egly JM, Coin F. True lies: the double life of the nucleotide excision repair factors in transcription and DNA repair. J Nucleic Acids 2010;19:1–11.
   Google Scholar
• Liu H, Rudolf J, Johnson KA, McMahon SA, Oke M, Carter L, et al. Structure of the DNA repair helicase XPD. Cell 2008;133:801–12.
   PubMed Web of Science ®Google Scholar
• Shuck SC, Short EA, Turchi JJ. Eukaryotic nucleotide excision repair: from understanding mechanisms to influencing biology. Cell Res 2008;18:64–72.
   PubMed Web of Science ®Google Scholar
• Osawa K. Gene polymorphisms and chemotherapy in non-small cell lung cancer. Chin J Lung Cancer 2009;12:837–40.
   Google Scholar
• Wang F, Chang D, Hu FL, Sui H, Han B, Li DD, et al. DNA repair gene XPD polymorphisms and cancer risk: a meta-analysis based on 56 case-control studies. Cancer Epidemiol Biomarkers Prev. 2008;17:507–17.
   PubMed Web of Science ®Google Scholar
• Kuptsova N, Ambrosone CP, Weiss J, Baer MR, Sucheston LE, Zirpoli G, et al. XPD DNA nucleotide excision repair gene polymorphisms associated with DNA repair deficiency predict better treatment outcomes in secondary acute myeloid leukemia. Int J Mol Epidemiol Genet. 2010;1:278–94.
   PubMedGoogle Scholar
• Estey EH. Acute myeloid leukemia: 2013 update on risk-stratification and management. Am J Hematol. 2013;88(4):318–27. doi: 10.1002/ajh.23404.
   PubMed Web of Science ®Google Scholar
• National Cancer Institute: Common terminology criteria for adverse events, v. 4.0. Available from: http://ctep.cancer.gov/reporting/ctc.html.
   Google Scholar
• Batar B, Güven M, Bariş S, Celkan T, Yildiz I. DNA repair gene XPD and XRCC1 polymorphisms and the risk of childhood acute lymphoblastic leukemia. Leuk Res. 2009;33(6):759–63. doi: 10.1016/j.leukres.2008.11.005 . Epub 2008 Dec 19.
   PubMed Web of Science ®Google Scholar
• Heo SG, Hong EP, Park JW. Genetic risk prediction for normal-karyotype acute myeloid leukemia using whole-exome sequencing. Genom Inform. 2013;11(1):46–51. doi: 10.5808/GI.2013.11.1.46 . Epub 2013 Mar 31.
   PubMedGoogle Scholar
• Manuguerra M, Saletta F, Karagas MR, Berwick M, Veglia F, Vineis P, et al. XRCC3 and XPD/ERCC2 single nucleotide polymorphisms and the risk of cancer: a HuGE review. Am J Epidemiol. 2006;164(4):297–302 . Epub 2006 May 17.
   PubMed Web of Science ®Google Scholar
• Crespan E, Garbelli A, Amoroso A, Maga G. Exploiting the nucleotide substrate specificity of repair DNA polymerases to develop novel anticancer agents. Molecules 2011;16(9):7994–8019. doi: 10.3390/molecules16097994.
   PubMed Web of Science ®Google Scholar
• Shen MR, Jones IM, Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res. 1998;58(4):604–8.
   PubMed Web of Science ®Google Scholar
• Spitz MR, Wu X, Wang Y, Wang LE, Shete S, Amos CI, et al. Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res. 2001;61(4):1354–7.
   PubMed Web of Science ®Google Scholar
• Rzeszowska-Wolny J, Polanska J, Pietrowska M, Palyvoda O, Jaworska J, Butkiewicz D, et al. Influence of polymorphisms in DNA repair genes XPD, XRCC1 and MGMT on DNA damage induced by gamma radiation and its repair in lymphocytes in vitro. Radiat Res. 2005;164(2):132–40.
   PubMed Web of Science ®Google Scholar
• Shen M, Berndt SI, Rothman N, Demarini DM, Mumford JL, He X, et al. Polymorphisms in the DNA nucleotide excision repair genes and lung cancer risk in Xuan Wei, China. Int J Cancer 2005;116(5):768–73.
   PubMed Web of Science ®Google Scholar
• Le Morvan V, Bellott R, Moisan F, Mathoulin-Pélissier S, Bonnet J, Robert J. Relationships between genetic polymorphisms and anticancer drug cytotoxicity vis-à-vis the NCI-60 panel. Pharmacogenomics 2006;7(6):843–52.
   PubMed Web of Science ®Google Scholar
• Lunn RM, Helzlsouer KJ, Parshad R, Umbach DM, Harris EL, Sanford KK, et al. XPD polymorphisms: effects on DNA repair proficiency. Carcinogenesis 2000;21(4):551–5.
   PubMed Web of Science ®Google Scholar
• Atkins CD. Single nucleotide polymorphisms and anthracycline cardiotoxicity in children: potential implications for adult oncology. J Clin Oncol. 2012;30(28):3563; author reply 3563–4. Epub 2012 Aug 27.
   PubMed Web of Science ®Google Scholar
• Guven M, Guven GS, Oz E, Ozaydin A, Batar B, Ulutin T, et al. DNA repair gene XRCC1 and XPD polymorphisms and their association with coronary artery disease risks and micronucleus frequency. Heart Vessels 2007;22(6):355–60 . Epub 2007 Nov 26.
   PubMed Web of Science ®Google Scholar
• Botto N, Masetti S, Petrozzi L, Vassalle C, Manfredi S, Biagini A, et al. Elevated levels of oxidative DNA damage in patients with coronary artery disease. Coron Artery Dis. 2002;13:269–274.
   PubMed Web of Science ®Google Scholar
• Frosina G. Overexpression of enzymes that repair endogenous damage to DNA. Eur J Biochem. 2000;267:2135–2149.
   PubMedGoogle Scholar
• Qiu M, Yang X, Hu J, Ding X, Jiang F, Yin R, et al. Predictive value of XPD polymorphisms on platinum-based chemotherapy in non-small cell lung cancer: a systematic review and meta-analysis. PLoS One 2013;8(8):e72251. doi: 10.1371/journal.pone.0072251.
   PubMed Web of Science ®Google Scholar
• Rumiato E, Cavallin F, Boldrin E, Cagol M, Alfieri R, Basso D, et al. ERCC1 C8092A (rs3212986) polymorphism as a predictive marker in esophageal cancer patients treated with cisplatin/5-FU-based neoadjuvant therapy. Pharmacogenet Genom. 2013;23(11):597–604.
   PubMed Web of Science ®Google Scholar